American Journal of Epidemiology Vol. 127, No. 2: 353-364
Copyright © 1988 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
EFFICACY OF SEQUENTIAL ANNUAL VACCINATION WITH INACTIVATED INFLUENZA VIRUS VACCINE1
Reprint requests to Dr. Wendy A. Keitel, Influenza Research Center, One Baylor Plaza, Houston, TX 77030
Inactivated influenza virus vaccine efficacy after annual revaccination has been reported to be less than that after first vaccination in boarding school children. We prospectively examined the immunogenicity and efficacy of this vaccine in healthy 30- to 60-year-old volunteers in Houston, Texas, over two epidemic seasons (1983–1985) encompassing outbreaks due to influenza A (H3N2 and H1N1) and influenza B viruses. A placebo group that had never (or not in recent years) received inactivated influenza virus vaccine, a group that received the vaccine for the first time (first vac), and a group given two or more recent vaccinations (multivac) were evaluated in a double-blind fashion each year. Vaccination induced higher frequencies of rise in serum antibody titer to vaccine components in first vac than in multivac volunteers, but mean postvaccination titers were similar. Clinical and virologic evaluations of illnesses during both epidemics and of influenza infections diagnosed serologically over the epidemic seasons revealed no overall reduction in illness from that in the placebo group for either vaccine group; modest reductions in influenza Infection-related illness that were significant only for the multivac group against Asol;H3N2-related illness (55%; p < 0.04); reduction in moderate-to-severe lower respiratory and/ or systemic illness due to influenza for multivac (73%, p < 0.025) but not first vac (15%, p > 0.10) volunteers during the A/H3N2 epidemic; reduction In influenza virus shedding In the multivac (54%, p < 0.05) but not the first vac (16%, p > 0.10) group when compared with the placebo group for both years; and overall 63–81% reductions in documented infections with each influenza virus for both vaccine groups with the exception of A/H1N1 for the first vac group (24%, p > 0.10) and type B for the multivac group (57%, p = 0.067). Vaccine efficacy was only modest in these studies, but in contrast to the earlier report in boarding school children, efficacy appeared to be somewhat greater after repeated annual vaccination than after first administration.
influenza; influenza vaccine; respiratory tract infections; vaccination
1Influenza Research Center, Department of Microbiology and Immunology, Baylor College of Medicine, Houston, TX.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A Holvast, C A Stegeman, C A Benne, A Huckriede, J C Wilschut, A M Palache, C G M Kallenberg, and M Bijl Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination Ann Rheum Dis, June 1, 2009; 68(6): 873 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N Wyatt, G. J Ryan, and K. A Sheerin Reduced-Dose Influenza Vaccine Ann. Pharmacother., September 1, 2006; 40(9): 1635 - 1639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lindsay, L. A. Jackson, D. A. Savitz, D. J. Weber, G. G. Koch, L. Kong, and H. A. Guess Community Influenza Activity and Risk of Acute Influenza-like Illness Episodes among Healthy Unvaccinated Pregnant and Postpartum Women Am. J. Epidemiol., May 1, 2006; 163(9): 838 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Langley and M. E. Faughnan Prevention of influenza in the general population Can. Med. Assoc. J., November 9, 2004; 171(10): 1213 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. G. Voordouw, M. C. J. M. Sturkenboom, J. P. Dieleman, Th. Stijnen, D. J. Smith, J. van der Lei, and B. H. Ch. Stricker Annual Revaccination Against Influenza and Mortality Risk in Community-Dwelling Elderly Persons JAMA, November 3, 2004; 292(17): 2089 - 2095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The American Lung Association Asthma Clinical Rese The Safety of Inactivated Influenza Vaccine in Adults and Children with Asthma N. Engl. J. Med., November 22, 2001; 345(21): 1529 - 1536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ahmed, J. A. Singleton, and A. L. Franks Influenza Vaccination for Healthy Young Adults N. Engl. J. Med., November 22, 2001; 345(21): 1543 - 1547. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Wilde, J. A. McMillan, J. Serwint, J. Butta, M. A. O'Riordan, and M. C. Steinhoff Effectiveness of Influenza Vaccine in Health Care Professionals: A Randomized Trial JAMA, March 10, 1999; 281(10): 908 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. E. P. Beyer, I. A. de Bruijn, A. M. Palache, R. G. J. Westendorp, and A. D. M. E. Osterhaus Protection Against Influenza After Annually Repeated Vaccination: A Meta-analysis of Serologic and Field Studies Arch Intern Med, January 25, 1999; 159(2): 182 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Small, B. S. Bender, F. Carrat, T. B. McCall, K. L. Nichol, and K. L. Margolis Vaccination against Influenza in Healthy Adults N. Engl. J. Med., February 8, 1996; 334(6): 402 - 404. [Full Text]
|
|
|
|
|
|
K. L. Nichol, A. Lind, K. L. Margolis, M. Murdoch, R. McFadden, M. Hauge, S. Magnan, and M. Drake The Effectiveness of Vaccination against Influenza in Healthy, Working Adults N. Engl. J. Med., October 5, 1995; 333(14): 889 - 893. [Abstract] [Full Text] [PDF]
|
|